Kratom Use Associated With Significant Toxicities
Most common effects include agitation, tachycardia, drowsiness, vomiting, confusion.
Pain Management
Most Adult-Use Cannabis Customers Use for Pain, Sleep Relief
Retail customers report decreases in prescriptions, over-the-counter meds due to effectiveness of cannabis.
The FDA Seeks Your Feedback on New Measure for Fixed-Quantity Blister Packaging for Opioids
The US Food and Drug Administration is seeking feedback from healthcare professionals on its proposal to offer fixed-quantity blister packaging for a select number of opioid medications.
Racial and Economic Disparities in Buprenorphine Prescriptions
Buprenorphine treatment may be more available to individuals who are white, use self-pay, or have private insurance.
Most Patients at High Risk of Opiate Overdose Do Not Receive Naloxone Rx
Only 1.5% of high-risk patients are prescribed naloxone upon ED or inpatient discharge.
US Lawmakers Say WHO Opioid Guidelines Too Lax
Organization claims guidelines influenced by people with financial ties to Purdue Pharma.
Usual Care vs Restrictive Strategy to Reduce Abdominal Pain in Patients With Gallstones
Patients who underwent cholecystectomy with either a usual care approach or a more restrictive selection strategy experienced a suboptimal reduction in abdominal pain.
FDA Launches “Remove the Risk” Campaign for Safe Disposal of Unused Opioids
The U.S. Food and Drug Administration is launching on April 25, 2019, its “Remove the Risk” campaign, aimed at promoting the safe disposal of unused opioids.
CDC Provides Clarification of Opioid Prescribing Guideline
Misapplication of the guideline can put patient health and safety at risk.
FDA Approves First Generic Nasal Spray Against Opioid Overdose
The first generic naloxone nasal spray to treat opioid overdose has received approval from the US Food and Drug Administration.
Next post in Pain Management Information Center
